AseptiScope, Inc. to Update Investors on the Emerging Growth Conference on May 9th, 2024

AseptiScope® invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.

San Diego, CA, May 2nd, 2024 / Digital Release / AseptiScope, Infection Prevention for Clinician and Patient (the “Company”) is pleased to announce that it will be giving an update on the Emerging Growth Conference on May 9th, 2024.

The next Emerging Growth Conference is presenting on May 9th, 2024. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s President & CEO, Scott Mader in real time.

To first view the Company’s previous presentations, visit:

https://www.youtube.com/watch?v=sVn3E-U1n_o

Mr. Mader will present an update and may subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Mader will do his best to get through as many of them as possible.

AseptiScope Co-Founder & CEO, Scott Mader

AseptiScope will be presenting at 2:55 PM Eastern time for 12 minutes.

Please register here to ensure you are able to attend the conference and receive any updates that are released:

https://goto.webcasts.com/starthere.jsp?ei=1658202&tp_key=3a47c30b43&sti=aseptiscope

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

About AseptiScope, Inc.

AseptiScope, Inc. (www.aseptiscope.com), formed in early 2016, is a privately funded San Diego, California-based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that offer “Infection Protection for Clinician & Patient.”  The company has launched the first true and practical solution for the longstanding challenge of stethoscope contamination: The DiskCover System.  Visit www.diskcover.com for more information or https://store.aseptiscope.com to purchase directly.

AseptiScope’s flagship product, The DiskCover® System, makes stethoscopes touch-free for patients.

Disclosure

AseptiScope, DiskCover, and related logos are registered trademarks of AseptiScope, Inc.

Media Contact:

Name: Anthony Pham

Email: apham@aseptiscope.com

Experts Recommend New Stethoscope Hygiene Standards To Address Patient Safety Risk

This image shows a clinician holding stethoscope whose diaphragm is protected by a disk cover barrier from The DiskCover System, the new stethoscope hygiene standard due to its efficacy and ease of use.
Effective stethoscope diaphragm barriers will elevate patient safety and protection from pathogens.

SAN DIEGO, Apr. 3, 2024 – Across time and around the world the symbol of healthcare, the stethoscope, remains the most commonly used medical device. Today’s publication in the Journal of Infection and Public Health¹ issues a clear message to the healthcare community.

Our stethoscopes are like our third hand, they touch our patients in each assessment, but in the process they spread pathogens just as unwashed hands. The data is consistent and clear on this, and we’ve been ignoring it for too long,” says Dr. Frank Peacock, an emergency physician at Baylor College of Medicine and an author of today’s publication. He and coauthors conducted a review and analysis of research associated with the stethoscope’s ability to transmit the pathogens that are of greatest concern – Multi Drug Resistant Organisms (MDROs).

Although stethoscope contamination is not new to the healthcare community, the practice of stethoscope hygiene between patients has not been reinforced.  “Even when clinicians do take the time to clean their stethoscopes by wiping it down with alcohol, resistant pathogens such as MRSA and C. diff spores still persist on the stethoscope diaphragm,” says Dr. Abhay Dhand, referring to the part of the stethoscope that touches the patient. Dhand is a coauthor and infectious disease expert at Westchester Medical Center in New York.

A representation of the spread of pathogens from patient to patient by a stethoscope diaphragm.
MDROs persist on the stethoscope diaphragm even after cleaning with alcohol, causing concerns for pathogen transmission to other patients.

On the west coast of the US things are no different; “I’ve conducted these studies myself”, says Alpesh Amin, MD, Professor of Medicine and Hospital Medicine expert at the University of California, Irvine. “Cleaning takes time and technique, it is not consistently done, and it still won’t remove dangerous, resistant pathogens known as MDROs. Over decades now, studies show this as a failed strategy”, Amin stated.

The expert analysis also looked at results for “single-patient stethoscopes” that are disposable tools assigned to one patient. “These blunt tools have not improved patient safety, and most data supports they may do the opposite”, states Cynthia Cadwell, NP, CPHQ, a patients safety expert, and coauthor. “Studies have shown that these poor quality products cause over 10% misdiagnoses, including critical cardiac pathologies like heart murmurs. Most data support that disposable stethoscopes do not prevent transmission, force clinicians to share contaminated earbuds, and contribute to increased material waste. These items have no redeeming value for the patient, the clinician, nor the environment”, concludes Cadwell.

The authors note that several studies in recent years have noted unprecedented blocking of stethoscope transmission using a clean barrier that shields patients during exams, allowing clinicians to use their stethoscopes with no acoustic interference. “Placing a barrier between the stethoscope and the patient ultimately makes stethoscope exams touch-free, essentially placing a clean glove on our third hand”, quips Alpesh Amin, credited for the stethoscope nickname in his 2015 study titled “The Third Hand²”.

Down the road from Dr. Amin, Dr. Francesca Torriani serves as Program Director of Infection Prevention and Clinical Epidemiology at University of California, San Diego Health. She has researched and published on the new, touch-free technology that automatically applies a clean, medical grade barrier on stethoscopes in about a second, immediately prior to the patient exam.

The technology, called The DiskCover System, is now available in the United States, and is gaining popularity. “We are now integrating it into routine use in several units with good reviews”. UC San Diego has installed The DiskCover System in UCSDH units and clinics throughout the city by integrating it into hand hygiene stations. “We have integrated hand hygiene into everything we do, so placing The DiskCover System next to hand hygiene stations, the staff automatically uses it,” Dr. Torriani advised.

This image shows The DiskCover System, a new and effective medical device and method for stethoscope hygiene.
A New Stethoscope Hygiene Standard: With The DiskCover System’s aseptic barriers, stethoscopes are now touch-free.

A new return-on-investment (ROI) analysis³ shows the touch-free, barrier technology, The DiskCover System, may save hospitals up to $5M annually. In a related move the CDC recently announced their new 2024 Guideline to Prevent Transmission of Pathogens in Healthcare Settings, replacing their antiquated old guidelines. The draft framework, now posted on the CDC website, repositions stethoscopes as vectors that transmit pathogens through touch, and that hygiene should be conducted “prior to use with other patients”, much more aligned with today’s hand hygiene requirements regulated by patient care oversight groups such as The Joint Commission.

The experts’ conclusions are that, based on the data, “the use of a practitioner’s personal stethoscope with a disposable diaphragm barrier should be considered as a significant improvement in patient safety… and considered as a potential new standard for all patient contacts.”

References:

  1. Stethoscope Barriers Narrative Review; It’s Time for a Strategy Unfriendly to Multi-Drug Resistant Organisms (MDROs) – ScienceDirect
  2. The Third Hand: Low Rates of Stethoscope Hygiene on General Medical Services (mdedge.com)
  3. Peacock WF. The Hidden Expense of Stethoscope Hygiene vs the Real Costs of Failure. Clin Exp Emerg Med. 2024 Jan 11. doi: 10.15441/ceem.23.161. Epub ahead of print. PMID: 38204157.